Indivior Pharmaceuticals, Inc. (INDV)
31.24
-0.74
(-2.31%)
USD |
NASDAQ |
Mar 03, 11:55
Indivior Pharmaceuticals EPS Diluted (Quarterly) : 0.816 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Apyx Medical Corp. | -0.0487 |
| Nephros, Inc. | 0.0305 |
| Owlet, Inc. | 0.1338 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 102.00M |
| Revenue (Quarterly) | 358.00M |
| Total Expenses (Quarterly) | 256.00M |
| Enterprise Value | 4.154B |
| Gross Profit Margin (Quarterly) | 82.12% |
| Profit Margin (Quarterly) | 28.49% |
| Earnings Yield | 5.32% |
| Operating Earnings Yield | 9.13% |
| Normalized Earnings Yield | 7.166 |